Epidemiology of SARS-CoV-2 infection and SARS-CoV-2 positive hospital admissions among children in South Africa.
COVID-19
adolescents
children
incidence
mortality
testing rate
Journal
Influenza and other respiratory viruses
ISSN: 1750-2659
Titre abrégé: Influenza Other Respir Viruses
Pays: England
ID NLM: 101304007
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
received:
14
09
2021
accepted:
15
09
2021
pubmed:
20
11
2021
medline:
5
1
2022
entrez:
19
11
2021
Statut:
ppublish
Résumé
We describe epidemiology and outcomes of confirmed SARS-CoV-2 infection and positive admissions among children <18 years in South Africa, an upper-middle income setting with high inequality. Laboratory and hospital COVID-19 surveillance data, 28 January - 19 September 2020 was used. Testing rates were calculated as number of tested for SARS-CoV-2 divided by population at risk; test positivity rates were calculated as positive tests divided by total number of tests. In-hospital case fatality ratio (CFR) was calculated based on hospitalized positive admissions with outcome data who died in-hospital and whose death was judged SARS-CoV-2 related by attending physician. 315 570 children aged <18 years were tested for SARS-CoV-2; representing 8.9% of all 3 548 738 tests and 1.6% of all children in the country. Of children tested, 46 137 (14.6%) were positive. Children made up 2.9% (n = 2007) of all SARS-CoV-2 positive admissions to sentinel hospitals. Among children, 47 died (2.6% case-fatality). In-hospital deaths were associated with male sex [adjusted odds ratio (aOR) 2.18 (95% confidence intervals [CI] 1.08-4.40)] vs female; age <1 year [aOR 4.11 (95% CI 1.08-15.54)], age 10-14 years [aOR 4.20 (95% CI1.07-16.44)], age 15-17 years [aOR 4.86 (95% 1.28-18.51)] vs age 1-4 years; admission to a public hospital [aOR 5.07(95% 2.01-12.76)] vs private hospital and ≥1 underlying conditions [aOR 12.09 (95% CI 4.19-34.89)] vs none. Children with underlying conditions were at greater risk of severe SARS-CoV-2 outcomes. Children > 10 years, those in certain provinces and those with underlying conditions should be considered for increased testing and vaccination.
Identifiants
pubmed: 34796674
doi: 10.1111/irv.12916
pmc: PMC9664941
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
34-47Subventions
Organisme : Medical Research Council
ID : MR/V028782/1
Pays : United Kingdom
Organisme : National Department of Health, Republic of South Africa
Informations de copyright
© 2021 The Authors. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd.
Références
Eur J Pediatr. 2020 Jul;179(7):1029-1046
pubmed: 32424745
Asian Pac J Allergy Immunol. 2020 Sep;38(3):170-177
pubmed: 32990448
MMWR Morb Mortal Wkly Rep. 2020 Aug 14;69(32):1081-1088
pubmed: 32790664
Pediatrics. 2020 Jun;145(6):
pubmed: 32179660
Paediatr Respir Rev. 2021 Jun;38:51-57
pubmed: 32891582
Commun Dis Intell (2018). 2020 Sep 9;44:
pubmed: 32907528
JAMA Pediatr. 2021 Feb 1;175(2):143-156
pubmed: 32975552
BMC Pediatr. 2020 Sep 1;20(1):410
pubmed: 32873269
Pediatr Pulmonol. 2020 Aug;55(8):1892-1899
pubmed: 32492251
Int J Prev Med. 2020 Jun 19;11:74
pubmed: 32742618
Lancet Child Adolesc Health. 2020 Sep;4(9):653-661
pubmed: 32593339
Front Public Health. 2020 Oct 19;8:504
pubmed: 33194933
Pediatr Pulmonol. 2020 Dec;55(12):3487-3496
pubmed: 32757374
J Clin Virol. 2020 Jul;128:104395
pubmed: 32417675
Epidemiol Infect. 2020 Sep 11;148:e208
pubmed: 32912370
JAMA Pediatr. 2020 Apr 8;:
pubmed: 32267485
JAMA Pediatr. 2020 Oct 1;174(10):e202430
pubmed: 32492092
EClinicalMedicine. 2020 Jun 26;24:100433
pubmed: 32766542
Clin Infect Dis. 2021 Jun 15;72(12):2215-2217
pubmed: 32710743
Trop Med Int Health. 2019 Jul;24(7):862-878
pubmed: 31002201
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464
pubmed: 32298251
J Microbiol Immunol Infect. 2021 Oct;54(5):839-844
pubmed: 32814650
Clin Infect Dis. 2020 Jul 28;71(15):875-878
pubmed: 32227121
N Engl J Med. 2014 Oct 2;371(14):1344-53
pubmed: 25265493
Pediatrics. 2020 Oct;146(4):
pubmed: 32665373
Tidsskr Nor Laegeforen. 2020 Jun 24;140(11):
pubmed: 32815353
Pediatr Res. 2021 Mar;89(4):733-737
pubmed: 32555539
Rev Med Virol. 2021 Jan;31(1):1-10
pubmed: 32845042
Pediatr Pulmonol. 2020 Aug;55(8):2115-2127
pubmed: 32519809
Pediatr Pulmonol. 2020 Oct;55(10):2556-2564
pubmed: 32710693
Infect Drug Resist. 2020 Jul 31;13:2649-2655
pubmed: 32801803
Influenza Other Respir Viruses. 2022 Jan;16(1):34-47
pubmed: 34796674
MMWR Morb Mortal Wkly Rep. 2020 Oct 23;69(42):1517-1521
pubmed: 33090984
J Med Virol. 2021 Feb;93(2):820-830
pubmed: 32691881
MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1324-1329
pubmed: 32941417
Acta Paediatr. 2020 Jun;109(6):1082-1083
pubmed: 32212348
Indian Pediatr. 2020 Sep 15;57(9):808-810
pubmed: 32651306